Literature DB >> 20673001

Transplantation of marrow-derived cardiac stem cells carried in fibrin improves cardiac function after myocardial infarction.

Hai-Dong Guo1, Hai-Jie Wang, Yu-Zhen Tan, Jin-Hong Wu.   

Abstract

The high death rate of the transplanted stem cells in the infarcted heart and the low efficiency of differentiation toward cardiomyocytes influence the outcome of stem cell transplantation for treatment of myocardial infarction (MI). Fibrin glue (FG) has been extensively used as a cell implantation matrix to increase cell survival. However, mechanisms of the effects of FG for stem cell transplantation to improve cardiac function are unclear. We have isolated c-kit+/Sca-1+ marrow-derived cardiac stem cells (MCSCs) from rat bone marrow; the cells expressed weakly early cardiac transcription factor Nkx2.5, GATA-4, Mef2C, and Tbx5. Effects of FG on survival, proliferation, and migration of MCSCs were examined in vitro. Cytoprotective effects of FG were assessed by exposure of MCSCs to anoxia. Efficacy of MCSC transplantation in FG was evaluated in the female rat MI model. The MCSCs survived well and proliferated in FG, and they may migrate out from the edge of FG in the wound and nature state. Acridine orange/ethidium bromide staining and lactate dehydrogenase analysis showed that MCSCs in FG were more resistant to anoxia as compared with MCSCs alone. In a rat MI model, cardiac function was improved and scar area was obviously reduced in group of MCSCs in FG compared with group of MCSCs and FG alone, respectively. Y chromosome fluorescence in situ hybridization showed that there were more survived MCSCs in group of MCSCs in FG than those in group of MCSCs alone, and most Y chromosome positive cells expressed cardiac troponin T (cTnT) and connexin-43 (Cx-43). Cx-43 was located between Y chromosome positive cells and recipient cardiomyocytes. Microvessel density in the peri-infarct regions and infarct regions significantly increased in group of MCSCs in FG. These results suggest that FG provide a suitable microenvironment for survival and proliferation of MCSCs and protect cells from apoptosis and necrosis caused by anoxia. MCSCs could differentiate into cardiomyocytes after being transplanted in the border of the infarcted myocardium and form connections with native cardiomyocytes. FG is helpful for MCSC transplantation to repair myocardium and improve cardiac function through promoting the survival, migration, and cardiomyogenic differentiation of MCSCs and inducing angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20673001     DOI: 10.1089/ten.TEA.2010.0124

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  30 in total

1.  A Regenerative Cardiac Patch Formed by Spray Painting of Biomaterials onto the Heart.

Authors:  Junnan Tang; Adam Vandergriff; Zegen Wang; Michael Taylor Hensley; Jhon Cores; Tyler A Allen; Phuong-Uyen Dinh; Jinying Zhang; Thomas George Caranasos; Ke Cheng
Journal:  Tissue Eng Part C Methods       Date:  2017-02-15       Impact factor: 3.056

2.  Cell-based therapy for heart failure in rat: double thoracotomy for myocardial infarction and epicardial implantation of cells and biomatrix.

Authors:  Aurélien Frobert; Jérémy Valentin; Stéphane Cook; Justine Lopes-Vicente; Marie-Noëlle Giraud
Journal:  J Vis Exp       Date:  2014-09-22       Impact factor: 1.355

Review 3.  New strategies for improving stem cell therapy in ischemic heart disease.

Authors:  Peisen Huang; Xiaqiu Tian; Qing Li; Yuejin Yang
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

4.  Immunobiology of fibrin-based engineered heart tissue.

Authors:  Lenard Conradi; Stephanie Schmidt; Evgenios Neofytou; Tobias Deuse; Laura Peters; Alexandra Eder; Xiaoqin Hua; Arne Hansen; Robert C Robbins; Ramin E Beygui; Hermann Reichenspurner; Thomas Eschenhagen; Sonja Schrepfer
Journal:  Stem Cells Transl Med       Date:  2015-05-06       Impact factor: 6.940

5.  Transplantation Effectiveness of Induced Pluripotent Stem Cells Is Improved by a Fibrinogen Biomatrix in an Experimental Model of Ischemic Heart Failure.

Authors:  Sebastian V Rojas; Andreas Martens; Robert Zweigerdt; Hassina Baraki; Christian Rathert; Natalie Schecker; Sara Rojas-Hernandez; Kristin Schwanke; Ulrich Martin; Axel Haverich; Ingo Kutschka
Journal:  Tissue Eng Part A       Date:  2015-07       Impact factor: 3.845

6.  Human umbilical cord stem cell encapsulation in novel macroporous and injectable fibrin for muscle tissue engineering.

Authors:  Jun Liu; Hockin H K Xu; Hongzhi Zhou; Michael D Weir; Qianming Chen; Carroll Ann Trotman
Journal:  Acta Biomater       Date:  2012-08-16       Impact factor: 8.947

7.  Cord lining-mesenchymal stem cells graft supplemented with an omental flap induces myocardial revascularization and ameliorates cardiac dysfunction in a rat model of chronic ischemic heart failure.

Authors:  Shera Lilyanna; Eliana C Martinez; Thang D Vu; Lieng H Ling; Shu U Gan; Ai L Tan; Thang T Phan; Theo Kofidis
Journal:  Tissue Eng Part A       Date:  2013-02-28       Impact factor: 3.845

8.  Fibrin glue improves the therapeutic effect of MSCs by sustaining survival and paracrine function.

Authors:  Inok Kim; Sung Koo Lee; Jung In Yoon; Da Eun Kim; Mihyung Kim; Hunjoo Ha
Journal:  Tissue Eng Part A       Date:  2013-07-16       Impact factor: 3.845

9.  Electrospun nanofibrous sheets of collagen/elastin/polycaprolactone improve cardiac repair after myocardial infarction.

Authors:  Yang Liu; Yachen Xu; Zhenhua Wang; Dezhong Wen; Wentian Zhang; Sebastian Schmull; Haiyan Li; Yao Chen; Song Xue
Journal:  Am J Transl Res       Date:  2016-04-15       Impact factor: 4.060

Review 10.  Materials science and tissue engineering: repairing the heart.

Authors:  Milica Radisic; Karen L Christman
Journal:  Mayo Clin Proc       Date:  2013-08       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.